RINOFLUIMUCIL

This brand name is authorized in Brazil, Ecuador, Hong Kong, Romania

Active ingredients

The drug RINOFLUIMUCIL contains a combination of these active pharmaceutical ingredients (APIs):

1 Acetylcysteine
UNII WYQ7N0BPYC - ACETYLCYSTEINE

Acetylcysteine is N-acetyl derivative of cysteine. Used as a mucolytic agent to reduce the viscosity of mucous secretions.

Read about Acetylcysteine
2 Tuaminoheptane
UNII WZK5LN5CNW - TUAMINOHEPTANE SULFATE
Read about Tuaminoheptane

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R01AB08 Tuaminoheptane R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AB Sympathomimetics, combinations excl. corticosteroids
Discover more medicines within R01AB08
R01AX Other nasal preparations R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use
Discover more medicines within R01AX

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 533801702176416, 533820080009507
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 5142-MEE-0520
Country: HK Department of Health Drug Office Identifier(s): 43293
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W53021001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.